Hydroxypinacolone Retinoate for Hyperpigmentation Dark Spots, Even Tone & UV Defense

Date:April. 09 2026

share:

Hydroxypinacolone Retinoate for Hyperpigmentation  Dark Spots, Even Tone & UV Defense

Hydroxypinacolone Retinoate (HPR) is a next-generation gentle Vitamin A that takes effect directly.

Targeting pigmentation and dark spots, clinical data shows that using a formulation containing 2% AC-HPR-S10 (containing 0.2% active HPR) for 4 consecutive weeks can significantly reduce the area of dark spots and enhance skin brightness (L-value), achieving an even and radiant complexion.

In terms of UV protection, HPR has been proven to be non-phototoxic. It can effectively inhibit UV-induced ROS (Reactive Oxygen Species) pathways, reducing free radical damage and collagen degradation.

When combined with 0.2% Glucosylrutin (GR), it can also slow down HPR degradation by 3%, providing you with a safe and efficient scientific solution for spot removal, brightening, and anti-photoaging.


Dark Spots

In daily skincare,Hydroxypinacolone Retinoate (HPR) can bind directly to cellular retinoic acid receptors without requiring metabolic steps.

Applying it every morning and evening for 28 consecutive days, the facial dark spot area index decreased from 14.39 to 8.11, and the skin brightness (L-value) rose from 68.23 to 69.10.

HPR blocks UV-induced ROS oxidative stress by reducing the activities of Phospholipase A (PLA) and Lipoxygenase (LOX), while inhibiting the NF-kB pathway to reduce the expression of pro-inflammatory proteins.

When skin is exposed to ultraviolet (UV) light, a large amount of reactive oxygen species (ROS) is produced within the tissues, prompting melanocytes to secrete melanin, which deposits on the skin surface to form dark spots.

After HPR (Hydroxypinacolone Retinoate) enters the skin, it binds directly with retinoic acid receptors (RARs) inside the cells.

Biological detection data shows that it can reduce the activity of Phospholipase A (PLA) and Lipoxygenase (LOX) in the human body.

By inhibiting these specific enzymes, HPR cuts off the melanin synthesis signaling triggered by oxidative stress.

In an in vivo clinical test targeting subjects aged 30 to 60, subjects applied a formula containing 2% AC-HPR-S10 (equivalent to an actual active HPR concentration of 0.2%) to their faces every morning and evening, with continuous observation for 4 weeks (28 days).


Various skin parameters read by instruments showed specific numerical changes:

Skin    Detection Index

Day 0    Baseline Data

Day 28    Test Data

Data    Change Description

Facial Dark Spot Area

14.39

8.11

Dark spot coverage shows a   significant reduction trend

Skin Brightness (L-value)

68.23

69.10

Overall facial skin fairness value   increased

Skin Radiance

7.53

8.60

Enhanced ability of the skin   surface to reflect light


Targeting different types of pigmentation, HPR operates within the skin in specific ways:

  • Reduction of Post-Inflammatory Hyperpigmentation (PIH): Dark acne marks or patches often remain after skin      inflammation. HPR interferes with the NF-kB signaling pathway, reducing      the expression of pro-inflammatory cytokines, thereby decreasing the      probability of pigment deposition during the inflammatory phase.

  • Acceleration of Pigmented Keratinocyte Shedding: HPR promotes the metabolism of epidermal cells. Aging      keratinocytes containing a large amount of melanin will slough off during      this process, causing the color of dark spots on the skin surface to fade.


At the raw material formulation level, the advanced version AC-HPR-W2 SACOS PRO includes Glucosylrutin (GR).

Adding 0.2% GR can protect HPR from degrading slower by 3%.

When users apply it during the day, the inherent antioxidant capacity of GR can resist damage to the skin from UV radiation, reducing the probability of new dark spot formation.

This attribute of 0 irritation reaction and non-phototoxicity allows users to continue using it every morning and evening to maintain an even facial complexion.

Hydroxypinacolone Retinoate for Hyperpigmentation  Dark Spots, Even Tone & UV Defense

Even Tone

As a Vitamin A derivative that binds directly to RAR receptors without metabolic steps, HPR at a 0.04% concentration can achieve the spot-fading and skin-brightening effects of 0.3% traditional Retinol.

Clinical human test data shows that after using a serum containing 0.2% active HPR twice daily for 28 consecutive days, the L-value representing facial skin brightness rose from 68.23 to 69.10, radiance improved from 7.53 to 8.60, and the area of localized dark spots significantly decreased.

In the 48-hour patch test, the 0.5% concentration of HPR showed no adverse reactions on human skin. Moreover, according to the results of the 3T3 NRU test, this ingredient is non-phototoxic.


Mechanism of HPR for Improving Complexion

When dealing with "uneven skin tone" in daily skincare, we primarily address melanin deposition and skin inflammation/redness caused by ultraviolet (UV) rays.

Traditional Retinol requires two metabolic steps to act on skin cells. This process easily causes redness and peeling, and some people may experience post-inflammatory hyperpigmentation (PIH) as a result, making parts of the skin look darker.

HPR is synthesized from retinoic acid and small-molecule pinacol.Masks the irritant groups of retinoids while improving stability.Retains the efficacy group of retinoic acid for direct binding to nuclear receptors.

In a 48-hour human patch test, a 0.5% concentration HPR solution resulted in zero irritation, and based on 3T3 NRU test standards, it has no phototoxicity.

From a cellular level, HPR reduces the NF-kB inflammatory pathway response caused by reactive oxygen species (ROS), lowering the production of related pro-inflammatory substances and reducing skin redness and subsequent melanin formation through physical pathways.


In Vivo Clinical Testing

In an in vivo clinical test targeting 15 healthy subjects aged 30 to 60, subjects applied a formulated product containing 2% AC-HPR-S10 (equivalent to an active HPR content of 0.2%) to their entire faces every morning and evening.

After 28 days of continuous use, the data measured by instruments showed a clear trend in complexion changes:

Test    Cycle

Skin    Brightness (L-value)

Skin    Radiance

Change in    Dark Spot Area

Day 0 (Baseline)

68.23

7.53

Baseline Area

Day 14

68.93

8.22

Visibly Reduced

Day 28

69.10

8.60

Continued Fading and Reduction


Data Description: L-value is a numerical value representing brightness in color space; higher values represent fairer and more radiant skin. The continuous rise in L-value and radiance over 28 days, combined with the reduction in localized dark spot area, indicates that HPR at a 0.2% concentration can even out the overall facial complexion within four weeks.

Formulation Pairings and Ingredient Synergies

According to formulation test data, HPR can improve the efficiency of complexion enhancement when used in combination with specific ingredients:

  • Pairing with Bakuchiol:      Bakuchiol can inhibit the activities of Phospholipase A (PLA) and      Lipoxygenase (LOX) in the skin. Used together, these two ingredients can      reduce oxidative skin damage. For those prone to acne, this combination      can help fade red acne marks and keep the facial complexion even.

  • Pairing with Glucosylrutin (GR): Glucosylrutin is added to the raw material AC-HPR-W2 SACOS      PRO. Test data indicates that adding 0.2% GR can reduce the thermal      degradation rate of HPR by 3%. This not only extends the effective shelf      life of HPR in the product but also provides additional antioxidant      capacity to prevent skin yellowing caused by free radical oxidation.

  • Compounding with Traditional Retinol: The EU limits the maximum concentration of Retinol in facial      skincare products to 0.3%. In terms of efficacy equivalence, only 0.04%      HPR is needed to achieve the same effect as 0.3% Retinol.

Hydroxypinacolone Retinoate for Hyperpigmentation  Dark Spots, Even Tone & UV Defense

UV Defense

HPR (Hydroxypinacolone Retinoate) binds directly to skin retinoic acid receptors, skipping the metabolic steps to intervene in photo-damage repair.

OECD TG432 in vitro testing proves that HPR is non-phototoxic.

It cuts off UV-induced lipid peroxidation by lowering PLA and LOX enzyme activities, blocks P38/MAPK and NF-kB signaling pathways, and reduces the production of matrix metalloproteinases (MMPs) and collagen loss.

UV radiation on the skin produces a large amount of reactive oxygen species (ROS), which activate specific proteases in the body.

HPR binds directly to retinoic acid receptors, intervening in the cellular cascade reactions caused by UV rays.

Specific repair and defense mechanisms are manifested in three dimensions:

  • Inhibition of Lipid Peroxidation: UV-generated ROS damage cell membrane structures. HPR reduces      the oxidative destruction of cell membrane unsaturated fatty acids by      lowering the activity of Phospholipase A (PLA) and Lipoxygenase (LOX).

  • Slowing Collagen Degradation:      UV rays activate the P38/MAPK signaling pathway, leading to an increase in      matrix metalloproteinases (MMPs) that break down collagen. HPR blocks this      pathway to reduce MMP production while stimulating the TGF-β/Smad pathway      to promote pro-collagen synthesis, replenishing lost collagen.

  • Alleviating Photo-damage Erythema: HPR can reduce the activation of the NF-kB complex mediated by      ROS, lowering the expression of pro-inflammatory substances and      alleviating symptoms of skin redness and heat after UV exposure.


Regarding the photosensitivity of the ingredient under UV light, the OECD TG432 in vitro 3T3 NRU phototoxicity test provides clear indicators.

The test primarily evaluates whether a substance produces phototoxic side effects after absorbing UV and visible light.

Test Item

Substance    Parameters and Test Conditions

Test    Method

Test    Results

In Vitro Phototoxicity Test

HPR(Dissolved in DMSO)

OECD TG432

No phototoxic reaction

Synergistic Photo-protection   Performance

0.2% Glucosylrutin (GR) + HPR

60°C heating and continuous   intense light irradiation

HPR degradation rate reduced by 3%


In actual skincare formulations, the HPR molecular structure contains double bonds, making it susceptible to oxidation during prolonged exposure to intense light.

Combining HPR with a 0.2% concentration of Glucosylrutin (GR) can slow down ingredient degradation under conditions of accelerated heating at 60°C and continuous light exposure.

In daily usage scenarios, using sunscreen alongside products containing HPR and antioxidant ingredients can effectively address daytime UV exposure and repair nighttime collagen loss.

 


Related News

REQUEST INFORMATION

Name
Company Name
Email
How can we help you

Hi! Cookies Statement

By clicking "Accept," you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.